CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
暂无分享,去创建一个
T. Standiford | R. Strieter | T. Moore | S. Lira | B. Mehrad | W. Tsai
[1] H. Etlinger,et al. the Journal of Immunology , 2006 .
[2] T. Standiford,et al. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. , 1999, Journal of immunology.
[3] 邦彦 小尾口. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia , 1999 .
[4] A. Mencacci,et al. Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. , 1998, The Journal of infectious diseases.
[5] H. Herschman,et al. The murine neutrophil‐chemoattractant chemokines LIX, KC, and MIP‐2 have distinct induction kinetics, tissue distributions, and tissue‐specific sensitivities to glucocorticoid regulation in endotoxemia , 1998, Journal of leukocyte biology.
[6] T. Standiford,et al. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. , 1998, Journal of immunology.
[7] K. Kooguchi,et al. Role of Alveolar Macrophages in Initiation and Regulation of Inflammation in Pseudomonas aeruginosaPneumonia , 1998, Infection and Immunity.
[8] E. Anaissie,et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] R. Terkeltaub,et al. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis. , 1998, Arthritis and rheumatism.
[10] L. Maltais,et al. Mouse cell surface antigens: nomenclature and immunophenotyping. , 1998, Journal of immunology.
[11] J. Paulauskis,et al. Concentration- and time-dependent upregulation and release of the cytokines MIP-2, KC, TNF, and MIP-1alpha in rat alveolar macrophages by fungal spores implicated in airway inflammation. , 1998, American journal of respiratory cell and molecular biology.
[12] H. Herschman,et al. Sequence similarities of a subgroup of CXC chemokines related to murine LIX: implications for the interpretation of evolutionary relationships among chemokines , 1997, Journal of leukocyte biology.
[13] H. Broxmeyer,et al. Impaired Host Defense, Hematopoiesis, Granulomatous Inflammation and Type 1–Type 2 Cytokine Balance in Mice Lacking CC Chemokine Receptor 1 , 1997, The Journal of experimental medicine.
[14] W. Leisenring,et al. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. , 1997, The Journal of infectious diseases.
[15] M. Dinauer,et al. Absence of Respiratory Burst in X-linked Chronic Granulomatous Disease Mice Leads to Abnormalities in Both Host Defense and Inflammatory Response to Aspergillus fumigatus , 1997, The Journal of experimental medicine.
[16] R. Strieter,et al. Transgenic methods to study chemokine function in lung and central nervous system. , 1997, Methods in enzymology.
[17] D. Denning. Therapeutic outcome in invasive aspergillosis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] P. Murphy,et al. The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor* , 1996, The Journal of Biological Chemistry.
[19] G. Opdenakker,et al. Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2. , 1996, Journal of immunology.
[20] A. Groll,et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. , 1996, The Journal of infection.
[21] S. Lira. Genetic approaches to study chemokine function , 1996, Journal of leukocyte biology.
[22] 諸橋寛寿. Expression of both types of human interleukin-8 receptors on mature neutrophils,monocytes,and natural killer cells , 1996 .
[23] T. Standiford,et al. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. , 1996, The Journal of infectious diseases.
[24] P. Murphy,et al. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. , 1996, The Journal of biological chemistry.
[25] W. Wood,et al. Chemokine binding and activities mediated by the mouse IL-8 receptor. , 1995, Journal of immunology.
[26] T. Standiford,et al. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. , 1995, Journal of immunology.
[27] M. Richardson,et al. Stimulation of neutrophil phagocytosis of Aspergillus fumigatus conidia by interleukin-8 and N-formylmethionyl-leucylphenylalanine. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[28] S. Allen,et al. Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis. , 1994, The Journal of antimicrobial chemotherapy.
[29] D. Carrasco,et al. Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells , 1994, The Journal of experimental medicine.
[30] M. Baggiolini,et al. Both interleukin‐8 receptors independently mediate chemotaxis , 1994 .
[31] J. Hoeffel,et al. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. , 1994, Journal of immunology.
[32] M. Jordana,et al. Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. , 1994, American journal of respiratory cell and molecular biology.
[33] M. Wallace,et al. Invasive aspergillosis in patients with AIDS. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] D. Johnson,et al. cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1). NAP-1 is highly conserved in guinea pig. , 1993, Journal of immunology.
[35] D. Venzon,et al. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon , 1993, Infection and immunity.
[36] K. Matsushima,et al. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8 , 1993, Nature.
[37] R. Horuk,et al. Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain. , 1993, The Journal of biological chemistry.
[38] T. Malek,et al. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. , 1993, Journal of immunology.
[39] J. Paulauskis,et al. Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. , 1992, The American journal of pathology.
[40] P. Leder,et al. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. , 1992, Science.
[41] M. Burdick,et al. The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. , 1992, Immunological investigations.
[42] M. Burdick,et al. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). , 1992, Immunological investigations.
[43] L. Taylor,et al. The interleukin-8 receptor is encoded by a neutrophil-specific cDNA clone, F3R. , 1991, The Journal of biological chemistry.
[44] M. Baggiolini,et al. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. , 1991, The Journal of biological chemistry.
[45] D. Denning,et al. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. , 1990, Reviews of infectious diseases.
[46] A. Cerami,et al. Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues , 1990, The Journal of experimental medicine.
[47] H. Malech,et al. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. , 1990, The Journal of infectious diseases.
[48] M. Dafonseca,et al. Flow cytometric analysis of recombinant murine GM-CSF (rmuGM-CSF) induced changes in the distribution of specific cell populations in vivo. , 1990, Cytometry.
[49] A. Cerami,et al. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] M. Baggiolini,et al. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.
[51] M. Baggiolini,et al. Mechanism of neutrophil activation by NAF, a novel monocyte‐derived peptide agonist , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[52] L. Moldawer,et al. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties , 1988, The Journal of experimental medicine.
[53] E. Butcher,et al. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. , 1987, Journal of immunology.
[54] T. Ganz,et al. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. , 1986, The Journal of infectious diseases.
[55] S. Goldblum,et al. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. , 1985, Journal of applied physiology.
[56] B. Strom,et al. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. , 1984, Annals of internal medicine.
[57] A. Schaffner,et al. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. , 1982, The Journal of clinical investigation.
[58] H. Malech,et al. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. , 1981, The American journal of medicine.
[59] B. Plikaytis,et al. Aspergillosis and other systemic mycoses. The growing problem. , 1979, JAMA.
[60] L. White,et al. Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigatus mycelium in mice , 1975, Infection and immunity.
[61] N. Rankin. Disseminated Aspergillosis and Moniliasis Associated with Agranulocytosis and Antibiotic Therapy , 1953, British medical journal.